5Dennis CL, Dowswell T. Interventions (other than pharmacologi- cal, psychosocial or psychological) for treating antenatal depres- sion[J]. Cochrane Database Syst Rev, 2013, 7 (7): 6795- 6802.
6Schildkrant JJ, Gordon EK, Durell J. Catecholamine metabolism in affective disorders. I. Normetanephrine and VMA excretion in depressed patients treated with imipramine [ J ]. J Psychiatr Res, 1965, 3(4): 213-218.
7Kyzar E, Stewart AM, Landsman S, et al. Behavioral effects of bidirectional modulators of brain monoamines reserpine and d-am- phetamine in zebrafish [J]. Brain Res, 2013, 1527 (8) : 108- 116.
8Brambilla F, Dalle Grave R, Calugi S, et al. Effects of cogni- tive-behavioral therapy on Eating Disorders cretory response to treatment [ J ]. Psychoneuroendocrinology, 2010, 35(5) : 729-737.
9Fountoulakis KN, Kelsoe JK, Akiskal H. Receptor targets for antidepressant therapy in bipolar disorder: an overview[J]. J Af- feer Disord, 2012, 138(3) : 222-238.
10Yaniv SP, Lueckj A, Klein E, et al. Dexamethasone enhances the norepinephrine-induced ERK/MAPK intracellular pathway possibly via dysregulation of the alpha2-adrenergic receptor: im- plications for antidepressant drug mechanism of action[ J]. Eur J cell Biol, 2010, 89(9) : 712-722.
